Personalized screening

Reaching more women in local communities, especially women of color, will ensure that the trial results apply to all women—and move health equity forward

The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.

Right now, researchers simply do not know whether one mammography method is better than another other at finding life-threatening breast cancers early.